KKB represents clients before the Drug Enforcement Administration and in litigation involving the regulation of controlled substances, List 1 chemicals, and anabolic steroids. These matters include issues pertaining to scheduling, narcotic classification, quota allocation, and exempt status; as well as requirements relating to security, registration, import and export, records and reports, and related issues.